Himes Sells 10000 Shares of Seattle Genetics, Inc. (NASDAQ:SGEN) Stock

Lloyd Doyle
September 23, 2017

The shares were sold at an average price of $51.98, for a total value of $541,787.54. The Louisiana State Employees Retirement System holds 556,300 shares with $17.58 million value, down from 570,400 last quarter. General Electric Co now has $215.37B valuation. Stock rose 8.65% over the trailing 6 months.

In related news, CMO Jonathan G. Drachman sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, June 22nd. General Electric Company (NYSE:GE) has declined 4.46% since September 18, 2016 and is downtrending. It has underperformed by 30.76% the S&P500.

Seattle Genetics (NASDAQ:SGEN) last issued its quarterly earnings data on Thursday, July 27th. SGEN's SI was 11.62M shares in September as released by FINRA.

Dodge & Cox increased Eli Lilly & Co (NYSE:LLY) stake by 5.96M shares to 5.99M valued at $493.14M in 2017Q2. State Street Corp boosted its position in shares of Seattle Genetics by 10.9% in the first quarter. The SI to Seattle Genetics Incorporated's float is 12.15%. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since September 18, 2016 and is uptrending. (NASDAQ:SGEN) stock went gone down with a prior 52-week high of $75.36.

Since March 31, 2017, it had 0 insider purchases, and 5 selling transactions for $3.74 million activity. IMMELT JEFFREY R bought $2.81 million worth of General Electric Company (NYSE:GE) on Monday, May 15. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. Therefore 100% are positive. General Electric Company had 58 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained the stock with "Buy" rating in Monday, June 12 report. The company now has an average rating of Hold and an average target price of $61.77. Argus Research maintained General Electric Company (NYSE:GE) on Wednesday, December 23 with "Buy" rating. The rating was maintained by Stifel Nicolaus with "Buy" on Tuesday, June 13. The firm has "Buy" rating given on Monday, October 10 by. Company insiders own 34.70% of the company's stock. The firm has "Equal-Weight" rating by Barclays Capital given on Tuesday, November 29. The rating was maintained by Leerink Swann on Friday, August 14 with "Outperform".

Analysts await General Electric Company (NYSE:GE) to report earnings on October, 20 before the open. During the same period a year ago, the business posted ($0.23) EPS. The biotechnology company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.42) by $0.03. Its down 0.03, from 0.82 in 2016Q3. It dropped, as 85 investors sold GE shares while 816 reduced holdings. Northwestern Mutual Wealth Com reported 293 shares or 0% of all its holdings. Knott David M reported 4,680 shares or 0.07% of all its holdings. Company's RSI at present is 56.37. Edgemoor Invest Advsr reported 656,035 shares. Ls Invest Advisors Ltd Llc owns 0% invested in Patrick Industries, Inc. Morgan Stanley reported 362,074 shares stake. Mitsubishi UFJ Kokusai Asset Management Co. Lombard Odier Asset Management (Europe) Limited holds 1.35% or 118,015 shares in its portfolio. Ftb holds 235 shares or 0% of its portfolio. A 6 analysts rate it as either a buy or a strong buy, while1 believe that investors should either steer clear of SGEN or, if they already own its stock, sell it. Therefore 40% are positive. (NASDAQ:PATK) has "Buy" rating given on Wednesday, August 30 by Robert W. Baird. The firm has "Neutral" rating given on Thursday, March 31 by CL King. The company's market capitalization is $9.08 billion.

Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of Seattle Genetics, Inc. (NASDAQ:SGEN) on Monday, September 14 with "Outperform" rating. Cantor Fitzgerald set a $43.00 target price on shares of Seattle Genetics and gave the stock a "hold" rating in a report on Monday, June 19th. About 45,216 shares traded. On Thursday, January 21 the stock rating was initiated by Credit Suisse with "Outperform".

Additionally, here are a few investment firms who have increased or decreased their stake in (SGEN). Its down 0.20, from 1.5 in 2016Q3. On average, equities analysts predict that Seattle Genetics, Inc. will post ($1.68) earnings per share for the current fiscal year. Noting its average daily volume at 1.23 million shares each day over the month, this signifies a pretty significant change over the norm.

RBC Capital began new coverage on Seattle Genetics, Inc. giving the company a "outperform" rating.

Several equities analysts have issued reports on the stock. Tokio Marine Asset Mngmt Communications Limited has invested 0.22% of its portfolio in Seattle Genetics, Inc. First Quadrant Ltd Partnership Ca has invested 0% in Seattle Genetics, Inc. Nv5 Global Inc (NASDAQ:NVEE) was reduced too. D E Shaw Inc accumulated 64,381 shares. Cantor Fitzgerald maintained Seattle Genetics, Inc.

More notable recent Seattle Genetics, Inc. (NASDAQ:SGEN) now have an ABR of 2.46.which is marked on a basic 1 to 5 scale, where 1 stands for a Strong Buy and 5 represents Strong Sell. Fincl Bank Of America De reported 452,927 shares.

About Seattle Genetics Seattle Genetics, Inc is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer. (NASDAQ:SGEN) for 88,500 shares.

Other reports by Iphone Fresh

Discuss This Article